Amberjack Capital Partners, L.P. has disclosed a substantial investment in Innovex International Inc., with holdings valued at $544.5 million as of September 30, 2025. This significant stake highlights Amberjack's strategic positioning within the financial services sector and showcases its active management approach.

Amberjack Capital Partners is a limited partnership based in Houston, Texas. The firm specializes in investment management and is registered with the SEC. Its recent filing, dated November 2, 2026, falls under the 13F-HR category, which is used by institutional investment managers to report their holdings.

According to the filing, Amberjack holds 29,369,822 shares of Innovex International Inc., indicating a strong commitment to this particular investment. The filing states, "The total value of the shares held is $544,516,500," reflecting the firm's confidence in Innovex's potential for growth.

This disclosure may impact various stakeholders, including investors, analysts, and competitors within the financial services sector. As Amberjack continues to build its portfolio, other firms may analyze this move to gauge market trends and investment strategies.

Looking ahead, it is unclear what specific actions Amberjack Capital will take next regarding its investment in Innovex International Inc. The filing does not specify any forthcoming decisions or changes.

Investment Details

Amberjack Capital Partners, L.P. reported holding a total of 29,369,822 shares of Innovex International Inc., classified under the common stock category. The investment is categorized as having sole investment discretion, indicating that Amberjack has full authority over the management of this investment without shared interests.

The filing also specifies that the total value of the shares held amounts to $544,516,500, reinforcing the firm's significant stake in Innovex. This level of investment underscores Amberjack's confidence in the company's future prospects.

Company Information

Amberjack Capital Partners, L.P. is incorporated in Delaware and has its business operations based in Houston, Texas. The firm’s address is listed as 3355 W. Alabama St., Suite 730, Houston, TX 77098. The Chief Compliance Officer, John Christopher Trampe, signed the filing, further emphasizing the firm's commitment to regulatory compliance.

The filing does not provide any details regarding the specific strategies Amberjack may employ in managing its investment in Innovex International Inc. or any potential future transactions related to this holding.